The global market for Sustained-release Medicine was valued at US$ 39190 million in the year 2024 and is projected to reach a revised size of US$ 62080 million by 2031, growing at a CAGR of 6.9% during the forecast period.

Sustained-release Medicine Market

Sustained-release Medicine refer to preparations that can be continuously released for a long time after administration to achieve long-acting effects, and the drug release is mainly a first-order rate process. Controlled release preparations (controlled release preparations) refer to the preparations that can automatically release the drug at a predetermined speed within a predetermined time, so that the blood drug concentration can be kept constant within the effective concentration range for a long time.

Since there is no difference between sustained-release preparations and controlled-release preparations in the some countries, so, in this report, Extended release (ER), Sustained release (SR), Controlled release (CR) and Delayed release (D

The main global manufacturers of sustained-release drugs are Sanofi, Novartis, Bayer, Johnson & Johnson, Takeda, AstraZeneca, AbbVie, etc. The top seven manufacturers occupy a total market share of nearly 35%, of which the largest manufacturer is Sanofi, with a market share of 10.85%. Global sustained-release drug production regions are mainly located in Europe, the United States, China, etc., of which the top two regions occupy more than 65% of the market share. In terms of their product categories, original ground medicine have a higher market share of 63.96%, while generics have a lower share.

This report aims to provide a comprehensive presentation of the global market for Sustained-release Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sustained-release Medicine.

The Sustained-release Medicine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sustained-release Medicine market comprehensively. Regional market sizes, concerning products by Type, by Distribution Channel, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Sustained-release Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Distribution Channel, and by regions.

Market Segmentation

Scope of Sustained-release Medicine Market Report

Report Metric	Details
Report Name	Sustained-release Medicine Market
Accounted market size in year	US$ 39190 million
Forecasted market size in 2031	US$ 62080 million
CAGR	6.9%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Original Ground Medicine Generic Medicine
Segment by Distribution Channel	Hospital Drugstore Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Sanofi, Novartis, Bayer, Johnson & Johnson, Takeda, AstraZeneca, AbbVie, Pfizer, Collegium Pharmaceutical, Inc, Endo Pharmaceuticals, Shanghai Shyndec Pharmaceutical, Zhuhai Rundu Pharmaceutical, China Res Double-Crane
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Distribution Channel, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sustained-release Medicine company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Distribution Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Sustained-release Medicine Market growing?

Ans: The Sustained-release Medicine Market witnessing a CAGR of 6.9% during the forecast period 2025-2031.

What is the Sustained-release Medicine Market size in 2031?

Ans: The Sustained-release Medicine Market size in 2031 will be US$ 62080 million.

What is the market share of major companies in Sustained-release Medicine Market?

Ans: The top seven manufacturers occupy a total market share of nearly 35%, of which the largest manufacturer is Sanofi, with a market share of 10.85%.

What is the Sustained-release Medicine Market share by type?

Ans: In terms of their product categories, original ground medicine have a higher market share of 63.96%, while generics have a lower share.

Who are the main players in the Sustained-release Medicine Market report?

Ans: The main players in the Sustained-release Medicine Market are Sanofi, Novartis, Bayer, Johnson & Johnson, Takeda, AstraZeneca, AbbVie, Pfizer, Collegium Pharmaceutical, Inc, Endo Pharmaceuticals, Shanghai Shyndec Pharmaceutical, Zhuhai Rundu Pharmaceutical, China Res Double-Crane

What are the Type segmentation covered in the Sustained-release Medicine Market report?

Ans: The Types covered in the Sustained-release Medicine Market report are Original Ground Medicine, Generic Medicine

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Sustained-release Medicine Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Original Ground Medicine

1.2.3 Generic Medicine

1.3 Market by Distribution Channel

1.3.1 Global Sustained-release Medicine Market Growth by Distribution Channel: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Drugstore

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Sustained-release Medicine Market Perspective (2020-2031)

2.2 Global Sustained-release Medicine Growth Trends by Region

2.2.1 Global Sustained-release Medicine Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Sustained-release Medicine Historic Market Size by Region (2020-2025)

2.2.3 Sustained-release Medicine Forecasted Market Size by Region (2026-2031)

2.3 Sustained-release Medicine Market Dynamics

2.3.1 Sustained-release Medicine Industry Trends

2.3.2 Sustained-release Medicine Market Drivers

2.3.3 Sustained-release Medicine Market Challenges

2.3.4 Sustained-release Medicine Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Sustained-release Medicine Players by Revenue

3.1.1 Global Top Sustained-release Medicine Players by Revenue (2020-2025)

3.1.2 Global Sustained-release Medicine Revenue Market Share by Players (2020-2025)

3.2 Global Sustained-release Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Sustained-release Medicine Revenue

3.4 Global Sustained-release Medicine Market Concentration Ratio

3.4.1 Global Sustained-release Medicine Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Sustained-release Medicine Revenue in 2024

3.5 Global Key Players of Sustained-release Medicine Head office and Area Served

3.6 Global Key Players of Sustained-release Medicine, Product and Application

3.7 Global Key Players of Sustained-release Medicine, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Sustained-release Medicine Breakdown Data by Type

4.1 Global Sustained-release Medicine Historic Market Size by Type (2020-2025)

4.2 Global Sustained-release Medicine Forecasted Market Size by Type (2026-2031)

5 Sustained-release Medicine Breakdown Data by Distribution Channel

5.1 Global Sustained-release Medicine Historic Market Size by Distribution Channel (2020-2025)

5.2 Global Sustained-release Medicine Forecasted Market Size by Distribution Channel (2026-2031)

6 North America

6.1 North America Sustained-release Medicine Market Size (2020-2031)

6.2 North America Sustained-release Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Sustained-release Medicine Market Size by Country (2020-2025)

6.4 North America Sustained-release Medicine Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Sustained-release Medicine Market Size (2020-2031)

7.2 Europe Sustained-release Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Sustained-release Medicine Market Size by Country (2020-2025)

7.4 Europe Sustained-release Medicine Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Sustained-release Medicine Market Size (2020-2031)

8.2 Asia-Pacific Sustained-release Medicine Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Sustained-release Medicine Market Size by Region (2020-2025)

8.4 Asia-Pacific Sustained-release Medicine Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Sustained-release Medicine Market Size (2020-2031)

9.2 Latin America Sustained-release Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Sustained-release Medicine Market Size by Country (2020-2025)

9.4 Latin America Sustained-release Medicine Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Sustained-release Medicine Market Size (2020-2031)

10.2 Middle East & Africa Sustained-release Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Sustained-release Medicine Market Size by Country (2020-2025)

10.4 Middle East & Africa Sustained-release Medicine Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Sanofi

11.1.1 Sanofi Company Details

11.1.2 Sanofi Business Overview

11.1.3 Sanofi Sustained-release Medicine Introduction

11.1.4 Sanofi Revenue in Sustained-release Medicine Business (2020-2025)

11.1.5 Sanofi Recent Development

11.2 Novartis

11.2.1 Novartis Company Details

11.2.2 Novartis Business Overview

11.2.3 Novartis Sustained-release Medicine Introduction

11.2.4 Novartis Revenue in Sustained-release Medicine Business (2020-2025)

11.2.5 Novartis Recent Development

11.3 Bayer

11.3.1 Bayer Company Details

11.3.2 Bayer Business Overview

11.3.3 Bayer Sustained-release Medicine Introduction

11.3.4 Bayer Revenue in Sustained-release Medicine Business (2020-2025)

11.3.5 Bayer Recent Development

11.4 Johnson & Johnson

11.4.1 Johnson & Johnson Company Details

11.4.2 Johnson & Johnson Business Overview

11.4.3 Johnson & Johnson Sustained-release Medicine Introduction

11.4.4 Johnson & Johnson Revenue in Sustained-release Medicine Business (2020-2025)

11.4.5 Johnson & Johnson Recent Development

11.5 Takeda

11.5.1 Takeda Company Details

11.5.2 Takeda Business Overview

11.5.3 Takeda Sustained-release Medicine Introduction

11.5.4 Takeda Revenue in Sustained-release Medicine Business (2020-2025)

11.5.5 Takeda Recent Development

11.6 AstraZeneca

11.6.1 AstraZeneca Company Details

11.6.2 AstraZeneca Business Overview

11.6.3 AstraZeneca Sustained-release Medicine Introduction

11.6.4 AstraZeneca Revenue in Sustained-release Medicine Business (2020-2025)

11.6.5 AstraZeneca Recent Development

11.7 AbbVie

11.7.1 AbbVie Company Details

11.7.2 AbbVie Business Overview

11.7.3 AbbVie Sustained-release Medicine Introduction

11.7.4 AbbVie Revenue in Sustained-release Medicine Business (2020-2025)

11.7.5 AbbVie Recent Development

11.8 Pfizer

11.8.1 Pfizer Company Details

11.8.2 Pfizer Business Overview

11.8.3 Pfizer Sustained-release Medicine Introduction

11.8.4 Pfizer Revenue in Sustained-release Medicine Business (2020-2025)

11.8.5 Pfizer Recent Development

11.9 Collegium Pharmaceutical, Inc

11.9.1 Collegium Pharmaceutical, Inc Company Details

11.9.2 Collegium Pharmaceutical, Inc Business Overview

11.9.3 Collegium Pharmaceutical, Inc Sustained-release Medicine Introduction

11.9.4 Collegium Pharmaceutical, Inc Revenue in Sustained-release Medicine Business (2020-2025)

11.9.5 Collegium Pharmaceutical, Inc Recent Development

11.10 Endo Pharmaceuticals

11.10.1 Endo Pharmaceuticals Company Details

11.10.2 Endo Pharmaceuticals Business Overview

11.10.3 Endo Pharmaceuticals Sustained-release Medicine Introduction

11.10.4 Endo Pharmaceuticals Revenue in Sustained-release Medicine Business (2020-2025)

11.10.5 Endo Pharmaceuticals Recent Development

11.11 Shanghai Shyndec Pharmaceutical

11.11.1 Shanghai Shyndec Pharmaceutical Company Details

11.11.2 Shanghai Shyndec Pharmaceutical Business Overview

11.11.3 Shanghai Shyndec Pharmaceutical Sustained-release Medicine Introduction

11.11.4 Shanghai Shyndec Pharmaceutical Revenue in Sustained-release Medicine Business (2020-2025)

11.11.5 Shanghai Shyndec Pharmaceutical Recent Development

11.12 Zhuhai Rundu Pharmaceutical

11.12.1 Zhuhai Rundu Pharmaceutical Company Details

11.12.2 Zhuhai Rundu Pharmaceutical Business Overview

11.12.3 Zhuhai Rundu Pharmaceutical Sustained-release Medicine Introduction

11.12.4 Zhuhai Rundu Pharmaceutical Revenue in Sustained-release Medicine Business (2020-2025)

11.12.5 Zhuhai Rundu Pharmaceutical Recent Development

11.13 China Res Double-Crane

11.13.1 China Res Double-Crane Company Details

11.13.2 China Res Double-Crane Business Overview

11.13.3 China Res Double-Crane Sustained-release Medicine Introduction

11.13.4 China Res Double-Crane Revenue in Sustained-release Medicine Business (2020-2025)

11.13.5 China Res Double-Crane Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Collegium Pharmaceutical, Inc.

Endo Pharmaceuticals

Shanghai Shyndec Pharmaceutical

Zhuhai Rundu Pharmaceutical

China Res Double-Crane

List of Tables

Table 1. Global Sustained-release Medicine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Original Ground Medicine

Table 3. Key Players of Generic Medicine

Table 4. Global Sustained-release Medicine Market Size Growth by Distribution Channel (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Sustained-release Medicine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Sustained-release Medicine Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Sustained-release Medicine Market Share by Region (2020-2025)

Table 8. Global Sustained-release Medicine Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Sustained-release Medicine Market Share by Region (2026-2031)

Table 10. Sustained-release Medicine Market Trends

Table 11. Sustained-release Medicine Market Drivers

Table 12. Sustained-release Medicine Market Challenges

Table 13. Sustained-release Medicine Market Restraints

Table 14. Global Sustained-release Medicine Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Sustained-release Medicine Market Share by Players (2020-2025)

Table 16. Global Top Sustained-release Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sustained-release Medicine as of 2024)

Table 17. Ranking of Global Top Sustained-release Medicine Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Sustained-release Medicine Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Sustained-release Medicine, Headquarters and Area Served

Table 20. Global Key Players of Sustained-release Medicine, Product and Application

Table 21. Global Key Players of Sustained-release Medicine, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Sustained-release Medicine Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Sustained-release Medicine Revenue Market Share by Type (2020-2025)

Table 25. Global Sustained-release Medicine Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Sustained-release Medicine Revenue Market Share by Type (2026-2031)

Table 27. Global Sustained-release Medicine Market Size by Distribution Channel (2020-2025) & (US$ Million)

Table 28. Global Sustained-release Medicine Revenue Market Share by Distribution Channel (2020-2025)

Table 29. Global Sustained-release Medicine Forecasted Market Size by Distribution Channel (2026-2031) & (US$ Million)

Table 30. Global Sustained-release Medicine Revenue Market Share by Distribution Channel (2026-2031)

Table 31. North America Sustained-release Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Sustained-release Medicine Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Sustained-release Medicine Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Sustained-release Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Sustained-release Medicine Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Sustained-release Medicine Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Sustained-release Medicine Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Sustained-release Medicine Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Sustained-release Medicine Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Sustained-release Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Sustained-release Medicine Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Sustained-release Medicine Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Sustained-release Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Sustained-release Medicine Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Sustained-release Medicine Market Size by Country (2026-2031) & (US$ Million)

Table 46. Sanofi Company Details

Table 47. Sanofi Business Overview

Table 48. Sanofi Sustained-release Medicine Product

Table 49. Sanofi Revenue in Sustained-release Medicine Business (2020-2025) & (US$ Million)

Table 50. Sanofi Recent Development

Table 51. Novartis Company Details

Table 52. Novartis Business Overview

Table 53. Novartis Sustained-release Medicine Product

Table 54. Novartis Revenue in Sustained-release Medicine Business (2020-2025) & (US$ Million)

Table 55. Novartis Recent Development

Table 56. Bayer Company Details

Table 57. Bayer Business Overview

Table 58. Bayer Sustained-release Medicine Product

Table 59. Bayer Revenue in Sustained-release Medicine Business (2020-2025) & (US$ Million)

Table 60. Bayer Recent Development

Table 61. Johnson & Johnson Company Details

Table 62. Johnson & Johnson Business Overview

Table 63. Johnson & Johnson Sustained-release Medicine Product

Table 64. Johnson & Johnson Revenue in Sustained-release Medicine Business (2020-2025) & (US$ Million)

Table 65. Johnson & Johnson Recent Development

Table 66. Takeda Company Details

Table 67. Takeda Business Overview

Table 68. Takeda Sustained-release Medicine Product

Table 69. Takeda Revenue in Sustained-release Medicine Business (2020-2025) & (US$ Million)

Table 70. Takeda Recent Development

Table 71. AstraZeneca Company Details

Table 72. AstraZeneca Business Overview

Table 73. AstraZeneca Sustained-release Medicine Product

Table 74. AstraZeneca Revenue in Sustained-release Medicine Business (2020-2025) & (US$ Million)

Table 75. AstraZeneca Recent Development

Table 76. AbbVie Company Details

Table 77. AbbVie Business Overview

Table 78. AbbVie Sustained-release Medicine Product

Table 79. AbbVie Revenue in Sustained-release Medicine Business (2020-2025) & (US$ Million)

Table 80. AbbVie Recent Development

Table 81. Pfizer Company Details

Table 82. Pfizer Business Overview

Table 83. Pfizer Sustained-release Medicine Product

Table 84. Pfizer Revenue in Sustained-release Medicine Business (2020-2025) & (US$ Million)

Table 85. Pfizer Recent Development

Table 86. Collegium Pharmaceutical, Inc Company Details

Table 87. Collegium Pharmaceutical, Inc Business Overview

Table 88. Collegium Pharmaceutical, Inc Sustained-release Medicine Product

Table 89. Collegium Pharmaceutical, Inc Revenue in Sustained-release Medicine Business (2020-2025) & (US$ Million)

Table 90. Collegium Pharmaceutical, Inc Recent Development

Table 91. Endo Pharmaceuticals Company Details

Table 92. Endo Pharmaceuticals Business Overview

Table 93. Endo Pharmaceuticals Sustained-release Medicine Product

Table 94. Endo Pharmaceuticals Revenue in Sustained-release Medicine Business (2020-2025) & (US$ Million)

Table 95. Endo Pharmaceuticals Recent Development

Table 96. Shanghai Shyndec Pharmaceutical Company Details

Table 97. Shanghai Shyndec Pharmaceutical Business Overview

Table 98. Shanghai Shyndec Pharmaceutical Sustained-release Medicine Product

Table 99. Shanghai Shyndec Pharmaceutical Revenue in Sustained-release Medicine Business (2020-2025) & (US$ Million)

Table 100. Shanghai Shyndec Pharmaceutical Recent Development

Table 101. Zhuhai Rundu Pharmaceutical Company Details

Table 102. Zhuhai Rundu Pharmaceutical Business Overview

Table 103. Zhuhai Rundu Pharmaceutical Sustained-release Medicine Product

Table 104. Zhuhai Rundu Pharmaceutical Revenue in Sustained-release Medicine Business (2020-2025) & (US$ Million)

Table 105. Zhuhai Rundu Pharmaceutical Recent Development

Table 106. China Res Double-Crane Company Details

Table 107. China Res Double-Crane Business Overview

Table 108. China Res Double-Crane Sustained-release Medicine Product

Table 109. China Res Double-Crane Revenue in Sustained-release Medicine Business (2020-2025) & (US$ Million)

Table 110. China Res Double-Crane Recent Development

Table 111. Research Programs/Design for This Report

Table 112. Key Data Information from Secondary Sources

Table 113. Key Data Information from Primary Sources

Table 114. Authors List of This Report

List of Figures

Figure 1. Sustained-release Medicine Picture

Figure 2. Global Sustained-release Medicine Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Sustained-release Medicine Market Share by Type: 2024 VS 2031

Figure 4. Original Ground Medicine Features

Figure 5. Generic Medicine Features

Figure 6. Global Sustained-release Medicine Market Size by Distribution Channel (2020-2031) & (US$ Million)

Figure 7. Global Sustained-release Medicine Market Share by Distribution Channel: 2024 VS 2031

Figure 8. Hospital Case Studies

Figure 9. Drugstore Case Studies

Figure 10. Other Case Studies

Figure 11. Sustained-release Medicine Report Years Considered

Figure 12. Global Sustained-release Medicine Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Sustained-release Medicine Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Sustained-release Medicine Market Share by Region: 2024 VS 2031

Figure 15. Global Sustained-release Medicine Market Share by Players in 2024

Figure 16. Global Top Sustained-release Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sustained-release Medicine as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Sustained-release Medicine Revenue in 2024

Figure 18. North America Sustained-release Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Sustained-release Medicine Market Share by Country (2020-2031)

Figure 20. United States Sustained-release Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Sustained-release Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Sustained-release Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Sustained-release Medicine Market Share by Country (2020-2031)

Figure 24. Germany Sustained-release Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Sustained-release Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Sustained-release Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Sustained-release Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Sustained-release Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Sustained-release Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Sustained-release Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Sustained-release Medicine Market Share by Region (2020-2031)

Figure 32. China Sustained-release Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Sustained-release Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Sustained-release Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Sustained-release Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Sustained-release Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Sustained-release Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Sustained-release Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Sustained-release Medicine Market Share by Country (2020-2031)

Figure 40. Mexico Sustained-release Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Sustained-release Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Sustained-release Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Sustained-release Medicine Market Share by Country (2020-2031)

Figure 44. Turkey Sustained-release Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Sustained-release Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Sustained-release Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Sanofi Revenue Growth Rate in Sustained-release Medicine Business (2020-2025)

Figure 48. Novartis Revenue Growth Rate in Sustained-release Medicine Business (2020-2025)

Figure 49. Bayer Revenue Growth Rate in Sustained-release Medicine Business (2020-2025)

Figure 50. Johnson & Johnson Revenue Growth Rate in Sustained-release Medicine Business (2020-2025)

Figure 51. Takeda Revenue Growth Rate in Sustained-release Medicine Business (2020-2025)

Figure 52. AstraZeneca Revenue Growth Rate in Sustained-release Medicine Business (2020-2025)

Figure 53. AbbVie Revenue Growth Rate in Sustained-release Medicine Business (2020-2025)

Figure 54. Pfizer Revenue Growth Rate in Sustained-release Medicine Business (2020-2025)

Figure 55. Collegium Pharmaceutical, Inc Revenue Growth Rate in Sustained-release Medicine Business (2020-2025)

Figure 56. Endo Pharmaceuticals Revenue Growth Rate in Sustained-release Medicine Business (2020-2025)

Figure 57. Shanghai Shyndec Pharmaceutical Revenue Growth Rate in Sustained-release Medicine Business (2020-2025)

Figure 58. Zhuhai Rundu Pharmaceutical Revenue Growth Rate in Sustained-release Medicine Business (2020-2025)

Figure 59. China Res Double-Crane Revenue Growth Rate in Sustained-release Medicine Business (2020-2025)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-19P19231

Tue Mar 18 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Sulpiride Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-38H9504

Tue Mar 18 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Rosuvastatin Methyl Ester Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-26T9550

Tue Mar 18 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Tolterodine Tartarate Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-21U9697

Tue Mar 18 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Sustained-release Medicine Market Research Report 2025

Published Date: March 2025

Report Code: QYRE-Auto-27L13848

Global Sustained-release Medicine Market Research Report 2025

FEATURED COMPANIES

Sustained-release Medicine Market Size

Sustained-release Medicine Market

Scope of Sustained-release Medicine Market Report

Chapter Outline

FAQ for this report

How fast is Sustained-release Medicine Market growing?

What is the Sustained-release Medicine Market size in 2031?

What is the market share of major companies in Sustained-release Medicine Market?

What is the Sustained-release Medicine Market share by type?

Who are the main players in the Sustained-release Medicine Market report?

What are the Type segmentation covered in the Sustained-release Medicine Market report?

FEATURED COMPANIES

RELATED REPORTS

$5800

Enterprise User

$5800

Enterprise User

$5800

Enterprise User

$5800

Enterprise User